ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Tiancheng Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0089-0712; OpenAlex author ID A5061294637. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity and Inform Therapeutic Strategies. Last author DOI 10.3390/biomedicines13123024 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yiming Li · 1 shared paper, 2025 · strength 0.25
- Paper Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity an… DOI 10.3390/biomedicines13123024 ↗
Kexin Chen · 1 shared paper, 2025 · strength 0.25
- Paper Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity an… DOI 10.3390/biomedicines13123024 ↗
Bin Xu · 1 shared paper, 2025 · strength 0.25
- Paper Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity an… DOI 10.3390/biomedicines13123024 ↗
Guanhu Yang · 1 shared paper, 2025 · strength 0.25
- Paper Single-Cell Sequencing Unravels Pancreatic Cancer: Novel Technologies Reveal Novel Aspects of Cellular Heterogeneity an… DOI 10.3390/biomedicines13123024 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.